ATE248373T1 - Funktioneller bioassay für an g-protein gekoppelte rezeptoragonisten und antagonisten - Google Patents
Funktioneller bioassay für an g-protein gekoppelte rezeptoragonisten und antagonistenInfo
- Publication number
- ATE248373T1 ATE248373T1 AT96918089T AT96918089T ATE248373T1 AT E248373 T1 ATE248373 T1 AT E248373T1 AT 96918089 T AT96918089 T AT 96918089T AT 96918089 T AT96918089 T AT 96918089T AT E248373 T1 ATE248373 T1 AT E248373T1
- Authority
- AT
- Austria
- Prior art keywords
- gpcrs
- antagonists
- identify
- indicator cells
- protein
- Prior art date
Links
- 238000004166 bioassay Methods 0.000 title abstract 2
- 239000000018 receptor agonist Substances 0.000 title abstract 2
- 229940044601 receptor agonist Drugs 0.000 title abstract 2
- 239000002464 receptor antagonist Substances 0.000 title abstract 2
- 229940044551 receptor antagonist Drugs 0.000 title abstract 2
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 abstract 6
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 abstract 6
- 239000000556 agonist Substances 0.000 abstract 2
- 239000005557 antagonist Substances 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000019522 cellular metabolic process Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47980395A | 1995-06-07 | 1995-06-07 | |
| PCT/US1996/008895 WO1996041169A1 (en) | 1995-06-07 | 1996-06-05 | Functional bioassay for g-protein coupled receptor agonists and antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE248373T1 true ATE248373T1 (de) | 2003-09-15 |
Family
ID=23905512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96918089T ATE248373T1 (de) | 1995-06-07 | 1996-06-05 | Funktioneller bioassay für an g-protein gekoppelte rezeptoragonisten und antagonisten |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0830600B1 (de) |
| JP (1) | JPH11507518A (de) |
| AT (1) | ATE248373T1 (de) |
| AU (1) | AU730875C (de) |
| CA (1) | CA2220715C (de) |
| DE (1) | DE69629684T2 (de) |
| DK (1) | DK0830600T3 (de) |
| WO (1) | WO1996041169A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2186979A1 (en) * | 1996-10-02 | 1998-04-02 | Michael Dennis | Methods of testing antagonists for their abilities to affect the activity of g protein-coulpled receptors |
| CA2192754A1 (en) | 1996-12-12 | 1998-06-12 | Jacques Drouin | Nur-re a response element which binds dimers of nur nuclear receptors and method of use therefor |
| US6403305B1 (en) * | 1997-02-06 | 2002-06-11 | Cornell Research Foundation, Inc. | Methods of identifying peptide agonists or negative antagonists of a G protein coupled receptor |
| EP0874047A3 (de) | 1997-04-22 | 2000-04-19 | Smithkline Beecham Corporation | CDNS Klon HMTMF81 der für einen neuen menschlichen 7-Transmembranrezeptor kodiert |
| EP0878542A3 (de) * | 1997-04-22 | 2000-04-19 | Smithkline Beecham Corporation | CDNS Klon HMTMF81 der für einen neuen menschlichen 7-Transmembranrezeptor kodiert |
| US20020146740A1 (en) * | 1997-10-09 | 2002-10-10 | William D. Huse | Method for identifying optimal binding ligands to a receptor |
| JP2002521681A (ja) * | 1998-07-31 | 2002-07-16 | アリーナ・フアーマシユーチカルズ・インコーポレーテツド | 内因性の構成的に活性化されるgタンパク質−共役オーファン受容体 |
| WO2001050127A2 (en) * | 1999-12-30 | 2001-07-12 | 7Tm Pharma | Screening using biological target molecules with metal-ion binding sites |
| US7732133B2 (en) | 2000-07-17 | 2010-06-08 | Chugai Seiyaku Kabushiki Kaisha | Screening methods for biologically active ligands |
| US6902902B2 (en) * | 2001-11-27 | 2005-06-07 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders |
| EP2490021A1 (de) * | 2011-02-18 | 2012-08-22 | Biotempt B.V. | Modulatoren von PRR- und GPCR-Signalisierung |
| KR101452864B1 (ko) | 2011-11-17 | 2014-11-04 | 서울대학교산학협력단 | Gpcr19 경로의 활성화에 의한 골수 유래 면역 조절 세포 및 면역 조절 b 림프구의 체내외 증폭 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993003137A1 (en) * | 1991-08-07 | 1993-02-18 | Washington University | Human substance p receptor |
| DK0647275T3 (da) * | 1992-06-23 | 2005-01-24 | Sinai School Medicine | Kloning og ekspression af receptoren for gonatotropin-frigörende hormon |
| WO1994009116A1 (en) * | 1992-10-15 | 1994-04-28 | Merck & Co., Inc. | Cho cells expressing human endothelin receptors |
| GB2283239A (en) * | 1993-10-29 | 1995-05-03 | Ucb Sa | Human H1 histamine receptor |
| US5677184A (en) * | 1994-04-19 | 1997-10-14 | Takeda Chemical Industries, Ltd. | CHO cells that express human LH-RH receptor |
-
1996
- 1996-06-05 CA CA002220715A patent/CA2220715C/en not_active Expired - Fee Related
- 1996-06-05 EP EP96918089A patent/EP0830600B1/de not_active Revoked
- 1996-06-05 AT AT96918089T patent/ATE248373T1/de not_active IP Right Cessation
- 1996-06-05 JP JP9501357A patent/JPH11507518A/ja not_active Ceased
- 1996-06-05 AU AU60437/96A patent/AU730875C/en not_active Ceased
- 1996-06-05 WO PCT/US1996/008895 patent/WO1996041169A1/en not_active Ceased
- 1996-06-05 DK DK96918089T patent/DK0830600T3/da active
- 1996-06-05 DE DE69629684T patent/DE69629684T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU6043796A (en) | 1996-12-30 |
| CA2220715C (en) | 2004-11-02 |
| AU730875B2 (en) | 2001-03-15 |
| EP0830600A1 (de) | 1998-03-25 |
| DK0830600T3 (da) | 2003-12-22 |
| DE69629684D1 (de) | 2003-10-02 |
| AU730875C (en) | 2003-01-16 |
| WO1996041169A1 (en) | 1996-12-19 |
| EP0830600A4 (de) | 2000-04-05 |
| EP0830600B1 (de) | 2003-08-27 |
| CA2220715A1 (en) | 1996-12-19 |
| JPH11507518A (ja) | 1999-07-06 |
| DE69629684T2 (de) | 2004-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69629684D1 (de) | Funktioneller bioassay für an g-protein gekoppelte rezeptoragonisten und antagonisten | |
| Tsuboi et al. | Prostanoid receptor subtypes | |
| Moore et al. | Cell-based versus isolated target screening: how lucky do you feel? | |
| Delapp et al. | Determination of [35S] guanosine-5′-O-(3-thio) triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay | |
| Gao et al. | Allosteric modulation and functional selectivity of G protein-coupled receptors | |
| Sugden et al. | Melatonin receptor pharmacology: toward subtype specificity | |
| Neher et al. | Intracellular calcium release mediated by two muscarinic receptor subtypes | |
| Lin et al. | Rapid measurements of intracellular calcium using a fluorescence plate reader | |
| Doijen et al. | Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool | |
| Price et al. | FlexStation examination of 5-HT3 receptor function using Ca2+-and membrane potential-sensitive dyes: advantages and potential problems | |
| DE69835301D1 (de) | Verfahren zur identifizierug oder testung von agonisten für bzw. antagonisten gegen ppar | |
| WO2000049416A3 (en) | Receptor assay for detecting an effect test compounds have on a particular membrane receptor | |
| CA2279881A1 (en) | A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease | |
| EP1012241A4 (de) | Testverfahren für agonisten und antagonisten des g protein gekoppelten rezeptors | |
| Benians et al. | The dynamics of formation and action of the ternary complex revealed in living cells using a G-protein-gated K+ channel as a biosensor | |
| EP1266037B1 (de) | High throughput screening durch messen der intrazellulären kalziumspiegel | |
| US6645733B1 (en) | Fluorescent intensity method for assaying binding between proteins or peptides | |
| Leitner et al. | The relationship between somatostatin binding and cyclic AMP-stimulated protein kinase inhibition | |
| Allen et al. | A homogeneous high throughput nonradioactive method for measurement of functional activity of Gs-coupled receptors in membranes | |
| Lundin et al. | Development of a time-resolved fluorescence resonance energy transfer assay (cell TR-FRET) for protein detection on intact cells | |
| Reinscheid et al. | High-throughput real-time monitoring of Gs-coupled receptor activation in intact cells using cyclic nucleotide-gated channels | |
| Zhang et al. | Action of alpha 2A-adrenergic receptors in circular smooth muscle of canine proximal colon | |
| WO1999055901A3 (en) | Screening assay for identifying human purinoreceptor ligands | |
| Crouch et al. | New strategies in drug discovery for GPCRs: high throughput detection of cellular ERK phosphorylation | |
| Varney et al. | Discovery of subtype-selective metabotropic glutamate receptor ligands using functional HTS assays |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |